| 专利名称 | GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS | ||
| 申请号 | WOEP18071478 | 申请日 | |
| 公开（公告）号 | WO2019030268A1 | 公开（公告）日 | 2018-08-08 |
| 申请（专利权）人 | 发明人 | KANNT Aimo; BIELOHUBY Maximilian; ELVERT Ralf; WAGNER Michael; BOSSART Martin; HAACK Torsten; KEIL Stephanie; SEIZ Werner | |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
The present invention relates to the medical use of specific GLP-1 /glucagon receptor agonists in the prevention and/or treatment of metabolic liver disease, particularly non-alcoholic fatty liver disease (NAFLD), more particularly non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and/or NAFLD-associated liver fibrosis. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
